Health In Tech reports strong Q1 2025 growth with 56% revenue increase and AI-backed underwriting advancements.

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

Dr Mujeeb Ur Rehman (principal investigator) alongside co-investigators Dr Muhammad Kazim and Dr Richard Smith, attended a ...

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Alberbury Young Farmers Club set themselves the huge ‘Peaks ‘n’ Pedals Charity Challenge’ and raised an incredible amount for charity ...

David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical Industry R&D, Drug Develo ...

Good morning, and welcome to Johnson & Johnson's First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode until the question-and-answer session of the conference. This ...

The Les Turner ALS Foundation’s 2025 Hoping Through Caring Gala raised more than $620,000 at the annual fundraising event ...

Thank you. We are both truly honoured to step into these leadership roles and continue the great work initiated by Nico, ...

It's done. You’ve had it.” My partner is grinning widely. I open my eyes but have no clue where I am. He tells me I had a ...

Presentation Operator Good morning, and welcome to Johnson Johnson's First Quarter 2025 Earnings Conference Call. [Operator ...